This briefing aims to deepen discussion on the Belt and Road Iniatiative (BRI) in Myanmar. The BRI is often described as a ‘grand strategy’ led by President Xi Jinping, centrally planned and rolled out by obedient state-owned enterprises (SOEs). The sheer size of the initiative – 136 countries have received US$90 billion in Chinese foreign direct investment and exchanged US$6 trillion in trade with China - can make the BRI appear monolithic and inevitable. However, using a political economy analysis, this briefing demonstrates that the BRI is not a grand strategy, but a broad framework of activities that seek to address a crisis in Chinese capitalism. An examination of four BRI projects in Myanmar using Chinese language sources shows the extent of lobbying by Chinese SOEs and the Yunnan provincial government to promote the projects, with support from the central Chinese government.
For decades, ketamine was only manufactured by pharmaceutical companies. Technically, it was too complicated to be made by amateur chemists. But in the past five years, that has changed. Chinese drug gangs have cracked the code, figuring out how to manufacture large batches of cheap ketamine. Drug traffickers don't bother to steal ketamine from legal sources anymore. Instead, they're making their own. It's largely a Chinese breakthrough.
The war on drugs is edging towards a truce. Half of Americans want to lift the ban on cannabis. America’s change of heart has led many to wonder if the UN conventions might be reformed to legalise some drugs and treat the use of others as a problem requiring health measures, not criminal or military ones. But as America has drawn back from prohibition, new drug warriors are stepping up to defend it. Russia is foremost among them. “The Russians have taken over the hard-line role that the US used to play,” says Martin Jelsma of the Transnational Institute.